Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment. (Record no. 14784060)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01979 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514183916.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200410s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1084-9785 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1089/108497804773391658 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Bushnell, David |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20041026 |
| 245 00 - TITLE STATEMENT | |
| Title | Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer biotherapy & radiopharmaceuticals |
| Date of publication, distribution, etc. | Feb 2004 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 35-41 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Amino Acids |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Arginine |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoid Tumor |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infusions, Intravenous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kidney |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lung Neoplasms |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lysine |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Meningioma |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Octreotide |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pancreatic Neoplasms |
| General subdivision | metabolism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Radiopharmaceuticals |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Yttrium Radioisotopes |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Menda, Yusuf |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | O'Dorisio, Thomas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Madsen, Mark |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Miller, Sara |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carlisle, Thomas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Squires, Shayne |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kahn, Daniel |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Walkner, Wayne |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Connolly, Mary |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | O'Dorisio, Sue |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Karwal, Mark |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ponto, James |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bouterfa, Hakim |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer biotherapy & radiopharmaceuticals |
| Related parts | vol. 19 |
| -- | no. 1 |
| -- | p. 35-41 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1089/108497804773391658">https://doi.org/10.1089/108497804773391658</a> |
| Public note | Available from publisher's website |
No items available.